JPRN-UMIN000004199招募中2 期
Phase II study of OK-432 intrapleural administration followed by systemic carboplatin, pemetrexed and bevasizumab for non-squamous non-small cell lung cancer with pleuritis carcinomatosa - Phase II study of OK-432 intrapleural administration followed by systemic carboplatin, pemetrexed and bevasizumab for non-squamous non-small cell lung cancer with pleuritis carcinomatosa
Kanagawa Cancaer Center0 个研究点目标入组 11 人开始时间: 2010年9月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Massive pericardial effusion 2)Severe complications; myocardial infarction, unstable angina, heart failure, uncontrolled hypertension, and unconrolled diabetis mellitus, uncontrolled infection. 3)Severe bone marrow suppression 4)Previous carboplatin allergy 5)Brain metastsis 6)Hemoptysis(more than 2.5ml), continuous or treatment-required bloody sputum 7)Lung fibrosis 8)Pregnancy 9)Other inappropriate cases
研究者
相似试验
进行中（未招募）
1 期
TILT - a trial of a bacterial agent called OK432, administered directly into the chest via an indwelling catheter in people with cancer of the lung lining (mesothelioma).MedDRA version: 20.0Level: PTClassification code 10059518Term: Pleural mesothelioma malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Malignant pleural mesotheliomaEUCTR2016-004727-23-GBorth Bristol NHS Trust Research & Innovation45
Unknown
不适用
The Efficacy of OK-432 Pleurodesis on Postoperative Air LeakPostoperative Air LeakNCT02502643National Taiwan University Hospital80
已完成
1 期
Efficacy of Pleurodesis When Accumulation of Fluids occurs in Fetal LungsFetal Bilateral Pleural EffusionReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12610000180011ational Science Council40
已完成
1 期
Phase I/II clinical trial of immunoRFA with OK-432 for patients with lung cancerlung cencer(lung neoplasms)JPRN-UMIN000007167Osaka City University, Department of Diagnostic and Interventional Radiology, Japan36
已完成
2 期
A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.chronic hepatitis BJPRN-UMIN000000692CHUGAI PHARMACEUTICAL CO.LTD.260